» Authors » Christos Tsatsanis

Christos Tsatsanis

Explore the profile of Christos Tsatsanis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 102
Citations 3307
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jesus R, Tsatsanis C, Moura C, Zanetta-Barbosa D, Stavropoulos A
Braz Oral Res . 2024 Jul; 38:e064. PMID: 39016370
The aim of this study was to evaluate the influence of implant macrodesign and surface hydrophilicity on osteoclast (OC) differentiation, activation, and survival in vitro. Titanium disks were produced with...
2.
Somalou P, Ieronymaki E, Feidaki K, Prapa I, Stylianopoulou E, Spyridopoulou K, et al.
Microorganisms . 2024 Feb; 12(2). PMID: 38399636
As the food and pharmaceutical industry is continuously seeking new probiotic strains with unique health properties, the aim of the present study was to determine the impact of short-term dietary...
3.
Vergadi E, Kolliniati O, Lapi I, Ieronymaki E, Lyroni K, Alexaki V, et al.
Nat Commun . 2024 Jan; 15(1):680. PMID: 38263289
The limited reserves of neutrophils are implicated in the susceptibility to infection in neonates, however the regulation of neutrophil kinetics in infections in early life remains poorly understood. Here we...
4.
Mateska I, Witt A, Hagag E, Sinha A, Yilmaz C, Thanou E, et al.
Elife . 2023 Jul; 12. PMID: 37449973
The hypothalamus-pituitary-adrenal (HPA) axis is activated in response to inflammation leading to increased production of anti-inflammatory glucocorticoids by the adrenal cortex, thereby representing an endogenous feedback loop. However, severe inflammation...
5.
Daskalaki M, Axarlis K, Tsoureki A, Michailidou S, Efraimoglou C, Lapi I, et al.
Mar Drugs . 2023 Jun; 21(6). PMID: 37367668
Obesity and type 2 diabetes are characterized by low-grade systemic inflammation and glucose intolerance, which can be partially controlled with nutritional interventions. Protein-containing nutritional supplements possess health-promoting benefits. Herein, we...
6.
Tammam M, Daskalaki M, Tsoureas N, Kolliniati O, Mahdy A, Kampranis S, et al.
Mar Drugs . 2023 Feb; 21(2). PMID: 36827120
The chemical investigation of the organic extract of the red alga collected from Hurghada reef in the Red Sea resulted in the isolation of five C acetogenins, including four tricyclic...
7.
Tsatsanis C, Elenkov A, Leijonhufvud I, Vaporidi K, Tivesten A, Giwercman A
Endocr Connect . 2023 Jan; 12(3). PMID: 36607156
Background: The risk of inflammatory diseases is sex-dependent, but it remains unknown whether this is due to the impact of sex hormones or sex chromosomes. Transgender individuals represent a unique...
8.
Stavropoulou E, Ieronymaki E, Dimitroulia E, Constantinidis T, Vrioni G, Tsatsanis C, et al.
Microorganisms . 2022 Dec; 10(12). PMID: 36557628
Honey has been shown to possess anti-inflammatory and bactericidal properties that may be useful for the prevention and treatment of infections as well as of acute and chronic inflammatory diseases....
9.
Al-Qahtani A, Pantazi I, Alhamlan F, Alothaid H, Matou-Nasri S, Sourvinos G, et al.
Front Immunol . 2022 Nov; 13:1020624. PMID: 36389723
Background: SARS-CoV-2 infects through the respiratory route and triggers inflammatory response by affecting multiple cell types including type II alveolar epithelial cells. SARS-CoV-2 triggers signals its Spike (S) protein, which...
10.
Pantazi I, Papafragkos I, Kolliniati O, Lapi I, Tsatsanis C, Vergadi E
Pathogens . 2022 Oct; 11(10). PMID: 36297190
Group B (GBS) is a gram-positive bacterium that is harmless for healthy individuals but may provoke invasive disease in young infants and immunocompromised hosts. GBS invades the epithelial barriers to...